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Thymocyte Resistance to Glucocorticoids Leads
to Antigen-Specific Unresponsiveness
Due to ªHolesº in the T Cell Repertoire
and differentiate into CD41CD82 or CD42CD81 (single-
positive) thymocytes, which migrate from the thymus
and become mature T cells (positive selection). Finally,
thymocytes with TCRs having high avidity for self-anti-
gen/MHC undergo activation-induced apoptosis (neg-
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immune tolerance to self. Thus, by determining in a TCR-National Institutes of Health
Bethesda, Maryland 20892 specific manner which thymocytes survive, selection
determines the available pool of peripheral receptors²Lymphocyte Biology Section
Laboratory of Immunology and thus the range of antigens to which mature T cells
can respond (the antigen-specific repertoire).National Institute of Allergy
and Infectious Diseases The means by which avidity ªwindowsº for positive
and negative selection are set is unclear. We have pro-National Institutes of Health
Bethesda, Maryland 20892 posed that glucocorticoids, which are synthesized by
thymic epithelial cells, determine which TCR avidities³Department of Immunology
Duke University Medical Center result in positive or negative selection by antagonizing
TCR-mediated thymocyte activation (Zacharchuk et al.,Durham, North Carolina 27710
1990, 1991; Vacchio et al., 1994, 1999). Glucocorticoids
prevent apoptosis produced by TCR occupancy in T cell
hybridomas and thymocytes (Zacharchuk et al., 1990;Summary
Iwata et al., 1991), and blockade of the glucocorticoid
receptor by RU-486 or prevention of glucocorticoid pro-We have proposed that glucocorticoids antagonize
TCR-mediated activation and influence which TCR duction in the thymus with the specific inhibitor metyra-
pone enhances TCR-mediated, antigen-specific dele-avidities result in positive or negative selection. We
now analyze the immune response of mice whose thy- tion of immature thymocytes (Vacchio et al., 1994).
Furthermore, inhibition of glucocorticoid production inmocytes express antisense transcripts to the gluco-
corticoid receptor (TKO mice). TKO mice responded thymic organ culture of TCRab-transgenic mice results
in apoptosis of double-positive thymocytes whose TCRsnormally to the complex antigen PPD but were prolifer-
ative nonresponders to pigeon cytochrome c 81-104 recognize self with an avidity that would normally result
in positive selection (Vacchio and Ashwell, 1997). Re-(PCC), having a large decrease in the frequency of
PCC-responsive CD41 T cells. Unlike wild-type T cells, cently, using MHC-congenic mice, we found that apo-
ptosis caused by inhibition of glucocorticoid biosynthe-few TKO T cells in PCC-specific cell lines expressed
Va111Vb31. Furthermore, for naive CD41 T cells from sis in fetal thymus organ culture was proportional to the
number of MHC-encoded molecules expressed (Vac-unimmunized TKO mice, the frequencies of many of
the molecular features common to the CDR3 regions chio et al., 1999). These data suggest that glucocorti-
coids inhibit TCR-mediated thymocyte activation, oneof PCC-responsive Va111Vb31 cells were substantially
decreased. Thus, thymocyte glucocorticoid hypore- result of which is to prevent thymocytes bearing TCRs
with very low (but still biologically significant) aviditysponsiveness resulted in loss of cells capable of re-
sponding to PCC, corresponding to an antigen-spe- for self-antigen/MHC from undergoing positive selection
and migration to the periphery. A diminished thymocytecific ªholeº in the T cell repertoire.
response to glucocorticoids would be predicted to shift
the normal positive selection window such that manyIntroduction
thymocytes that would normally undergo positive selec-
tion would be deleted, while some thymocytes bearingOne of the key functions of the thymus is to ensure that
TCRs that normally have inadequate avidity to preventthe cells it exports are capable of responding to foreign
default death would now be positively selected. Thebut not self-antigens presented by self major histocom-
validity of this hypothesis hinges on the prediction thatpatability complex (MHC)-encoded molecules (antigen/
the antigen-specific peripheral T cell repertoire shouldMHC). To accomplish this, developing thymocytes un-
change as a function of thymocyte exposure or responsedergo selection processes in which their fate is de-
to glucocorticoids.termined by the avidity of their T cell antigen recep-
To test this, we generated mice whose thymocytestors (TCRs) for self-antigen/MHC (Sprent et al., 1988;
but not peripheral T cells have low levels of the glucocor-Schwartz, 1989). The default outcome for CD41CD81
ticoid receptor (GR) due to the transgenic expression(double-positive) thymocytes bearing TCRs with sub-
of GR antisense transcripts driven by the lck proximalthreshold avidity is apoptosis (death by neglect). In con-
promoter (TKO mice) (King et al., 1995). These animalstrast, double-positive thymocytes that express recep-
have a small thymus with increased spontaneous apo-tors with moderate avidity for self-antigen/MHC survive
ptosis, and the double-positive thymocytes are unusu-
ally sensitive to TCR-induced cell death. The antigen-§ To whom correspondence should be addressed (e-mail: jda@
box-j.nih.gov). specific repertoire of TKO mice was probed by analyzing
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Figure 1. Proliferative Responses of T Cells from B10.BR and B10.BR.TKO Mice Immunized with PCC 81-104
Mice were immunized with 8 nmol PCC 81-104 in CFA. After 9 days, 105 T cells purified from the draining lymph nodes were incubated with
5 3 105 irradiated B10.BR spleen cells/well and the indicated concentrations of (A) anti-CD3, (B) PPD, or (C) PCC 81-104. A representative
experiment with three B10.BR and three B10.BR.TKO mice is shown.
their immune response to pigeon cytochrome c frag- or anti-CD3 antibodies as well as to TCR occupancy by
complex TCR ligands such as alloantigen (Tolosa et al.,ment 81-104 (PCC 81-104), a peptide to which mice of
the H-2k haplotype make a stereotyped immune re- 1998). To determine if glucocorticoids are involved in
shaping the antigen-specific T cell repertoire, the im-sponse in which the large majority of responding T cells
express TCRs containing Va11 and Vb3 (reviewed in mune response of TKO mice to foreign antigens was
determined. The COOH-terminal fragment of pigeon cy-Davis et al., 1995). We report here that TKO mice are
specifically unresponsive to PCC 81-104 but not to more tochrome c (PCC 81-104) was chosen as the immunogen
because of the narrow and stereotyped nature of the Tcomplex antigens due to the specific loss of T cells that
normally recognize this antigen. cell response it elicits from H-2k mice. PCC 81-104 is
presented by the I-Ek MHC-encoded molecule, and the
large majority of T cells that can be expanded fromResults
immunized mice express a TCR containing Va11 and
Vb3 (reviewed in Davis et al., 1995) with conservationB10.BR.TKO Mice Are Specifically Unresponsive
to PCC 81-104 of Ja and Jb use and specific residues in the CDR3
region (McHeyzer-Williams et al., 1999), making it possi-TKO animals express transgenic GR transcripts under
the control of the lck proximal promoter (King et al., ble to analyze the diversity of the T cell response to
PCC 81-104 at the molecular level.1995). Due to the tissue specificity of the promoter, GR
antisense transcripts are abundant in the thymus but The GR antisense transgene was introduced into the
C57BL strain by backcrossing the original TKO mice withalmost undetectable in the spleen. As a consequence,
GR levels are reduced z2-fold in the thymus, and dou- C57BL/6 mice for eight generations and then crossing
these animals with B10.BR mice to obtain animals homo-ble-positive thymocytes are hyporesponsive to gluco-
corticoid-induced gene transactivation and apoptosis. zygous for both GR antisense and H-2k (B10.BR.TKO).
B10.BR and B10.BR.TKO mice were immunized withDespite this, peripheral T cells do accumulate, and by
8±10 weeks of age these mice contain from 50%±70% PCC 81-104 in CFA, and 8±10 days later T cells were
purified from the draining lymph nodes and analyzedof the number of lymph node T cells found in wild-type
animals. Furthermore, these primary T cells respond for their proliferative response to various stimuli. Figure
1 contains data from a representative experiment innormally to mitogens such as concanavalin A (Con A)
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Figure 2. Cell Surface Phenotype of Lymph
Node Cells from B10.BR and B10.BR.TKO
Mice
(A) Lymph node cells from B10.BR and
B10.BR.TKO mice were stained for CD4 and
CD8. Profiles are gated as PI negative, low
for forward and obtuse light scatter, and pre-
sented as 5% probability contours. The num-
bers in the upper left and bottom right quad-
rants indicate percent CD41 and CD81 cells,
respectively.
(B) The same cells were stained for CD4,
CD3-e, and B220. Histograms are gated PI
negative, low for forward and obtuse light
scatter, B2202, and CD41.
which three B10.BR and three B10.BR.TKO mice were cells, or both. Although as noted previously the number
of lymph node T cells is modestly reduced in TKO micecompared. The spontaneous proliferation of T cells from
all animals as measured by [3H]thymidine incorporation (30%±50%) (Tolosa et al., 1998), their cell surface pheno-
type is similar to that of wild-type animals (Figure 2).was negligible, and T cells from each mouse proliferated
well and equivalently when stimulated with an anti-CD3 Expression of activation/differentiation markers such as
CD44, CD62L, and CD69 on TKO T cells is also normalantibody (Figure 1A). Because CFA contains killed Myco-
bacterium tuberculosis, immune responses generated
by immunization with this adjuvant will also include T
cells that respond to purified protein derivative (PPD),
a complex mixture of mycobacterial proteins. To assess
the ability of T cells from TKO mice to generate a poly-
clonal response to a complex antigen, the proliferative
response to PPD was determined (Figure 1B). All mice
responded to PPD, with no apparent differences be-
tween the wild-type and TKO mice. In fact, in this experi-
ment the mouse with the best response as measured
by the absolute amount of [3H]thymidine incorporated
was a B10.BR.TKO animal. Finally, the specific response
to PCC 81-104 was analyzed. T cells from wild-type
B10.BR mice responded in an antigen dose±dependent
manner (Figure 1C). In contrast, T cells from primed
B10.BR.TKO mice failed to proliferate when challenged
with PCC 81-104 in vitro. Therefore, while the T cells of
mice with reduced thymocyte GR levels were capable of
responding to stimulation with anti-CD3 and a complex
antigen such as PPD, they were unresponsive to PCC
81-104. Note that because the antisense transgene is
driven by the proximal lck promoter, it is not expressed
in peripheral T cells of TKO mice, for which GR levels Figure 3. Phenotype of PCC 81-104±Responsive Primary T Cells
and glucocorticoid responsiveness have been shown to B10.BR and B10.BR.TKO mice were immunized with PCC 81-104
be normal (King et al., 1995; Tolosa et al., 1998). and the draining lymph nodes removed 7 days later. After stimulation
with PCC 81-104 as described in Experimental Procedures, the cells
were stained for TCR Va11, TCR Vb3, anti-IFNg, and anti-IL-4. TheFrequency Analysis of PCC 81-104±Responsive
data were gated on TCR Va111 cells, and the Vb3 versus IFNgT Cells
expression profiles of 104 cells are shown. The percent of cells inThe failure of T cells from B10.BR.TKO mice to prolifer-
each quadrant is noted. (A) shows B10.BR mice, no antigen in vitro.
ate in response to PCC 81-104 could be a reflection of (B) shows B10.BR mice, PCC 81-104 stimulation in vitro. (C) shows
loss of the precursors that normally respond to this B10.BR.TKO mice, no antigen in vitro. (D) shows B10.BR.TKO mice,
PCC 81-104 stimulation in vitro.antigen, a decrease in the TCR avidity of the responding
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Figure 4. Surface Expression of CD3, Va11,
and Vb3 on PCC 81-104±Specific T Cell Lines
PCC 81-104-specific T cell lines were gener-
ated from B10.BR and B10.BR.TKO mice by
repeated cycles of antigen stimulation and
rest. Cells were triple stained with anti-CD3-
FITC, anti-TCR Vb3-PE, and anti-TCR Va11-
biotin followed by streptavidin-cy-chrome
and analyzed by FACScan. Ungated CD3
staining is shown (unstained controls are
shown with dashed lines), as is staining of
TCR Va11 and Vb3 after gating on CD31 cells.
The percent of cells in each quadrant is
noted.
(see below; data not shown). The frequency of re- B10.BR mice, IFNg-producing Va111Vb31 T cells were
8.2% 6 0.3% (n 5 4) of the CD41 PCC 81-104±responsivesponding cells was assessed by their ability to produce
pool. The fraction of CD41 Va111Vb31 PCC 81-104±cytokines upon restimulation in vitro. The draining lymph
responsive T cells from B10.BR.TKO mice was 4.2% 6nodes of B10.BR and B10.BR.TKO mice were harvested
0.37% (n 5 4), a decrease of approximately half. In7 days after immunization with PCC 81-104. After remov-
addition to the difference in responding cell number,ing CD81 cells, T cells were activated for 5 hr with PCC
individual T cells from B10.BR mice responded substan-81-104 plus mitomycin C±treated antigen-presenting
tially better than T cells from B10.BR.TKO animals. Thecells (APC), after which time four-color flow cytometric
mean fluorescence intensity (MFI) of IFNg1 staining foranalysis was performed for simultaneous detection of
B10.BR Va111Vb31 T cells was 227 6 21 (n 5 4) com-Va11, Vb3, IFNg, and IL-4. Representative results from
pared to 132 6 9 (n 5 4) for B10.BR.TKO Va111Vb31 Tone of four independent experiments are shown in Fig-
cells. Therefore, the number of T cells that respond to
ure 3. On average, the frequency of responding CD41
PCC 81-104 is substantially decreased in mice whose
T cells in B10.BR mice as judged by IFNg production thymocytes are hyporesponsive to glucocorticoids, and
was 1:213 6 7 (n 5 4). In contrast, the frequency of the T cells that do recognize this peptide are less respon-
IFNg-producing cells in B10.BR.TKO mice was 1:1053 6 sive on a per cell basis.
132, a decrease of 5-fold. No PCC 81-104-specific IL-41
cells were detected in either mouse (data not shown), PCC 81-104±Responsive T Cell Lines
consistent with the predominantly Th1-like response to Despite the poor proliferative response of immunized
immunization with PCC 81-104 in CFA (J. D. A., un- primary T cells from B10.BR.TKO mice, it was possible
published data). The fraction of responding CD41 T to generate antigen-specific T cell lines from these ani-
mals. To do this, lymph node cells were cultured withcells that were Va111Vb31 was also determined. For
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irradiated B10.BR splenocytes as a source of APC and
PCC 81-104, followed 48 hr later by the addition of
IL-2. Repetitive cycles of stimulation and rest led to
the generation of T cell lines from both B10.BR and
B10.BR.TKO mice. PCC 81-104±specific T cell lines and
clones are much more sensitive, on the order of 100-
fold, to simulation with antigen than primary T cells (Fox
et al., 1987; see below). To avoid biasing the composition
of the T cell lines toward those clones with the highest
avidity, a relatively high concentration of PCC 81-104 (5
mM) was used for initiation and propagation of the lines.
After 4±5 cycles of stimulation and rest, seven and nine
T cell lines from B10.BR and B10.BR.TKO mice, respec-
tively, were analyzed. All of the T cells in these lines
expressed CD3 (Figure 4) and CD4 but not CD8 (data
not shown). Consistent with many previous studies, PCC
81-104±responsive B10.BR T cell lines consisted largely
of Va111Vb31 T cells, with this subset constituting
86% 6 4.6% (n 5 7) of the T cells. Strikingly, only a
small fraction (9.2% 6 2.3%, n 5 9) of the T cells in
the lines derived from B10.BR.TKO mice expressed this
receptor (Figure 4).
T cell proliferation assays were performed to deter-
mine the sensitivity of the different T cell lines to PCC
81-104. Figure 5 contains one representative experi-
ment. All of the T cell lines proliferated in response to
PCC 81-104 in an antigen dose±responsive fashion. T
cell lines from both B10.BR and B10.BR.TKO mice were
restricted to the I-Ek molecule, as they proliferated when
B10.BR (I-Ak, I-Ek) but not B10.A(4R) (I-Ak, I-Eb) APC were
used to present PCC 81-104 (data not shown). There
was overlap in the proliferative response among the
lines, and it was not possible to distinguish between
those derived from B10.BR and B10.BR.TKO mice solely
on the basis of their sensitivity to antigen. However,
when the results of these and other experiments were
analyzed, it was found that B10.BR.TKO T cell lines
required 3- to 4-fold more antigen to achieve half-maxi-
mal proliferation than did B10.BR T cell lines, a statisti- Figure 5. PCC 81-104±Specific T Cell Lines from B10.BR.TKO Mice
cally significant difference (p , 0.05, Student's t test). Are Less Sensitive to Antigen
This difference is likely due to a generally lower avidity T cells (104) were cultured with 5 3 105 irradiated B10.BR spleen
of the TCRs expressed by the B10.BR.TKO T cells and cells and varying concentrations of PCC 81-104. The T cell lines are
numbered as in Figure 3. The data are expressed as the percent ofis a reflection of the decreased per cell responsiveness
maximal response for each T cell line. The range of responses forof primed T cells as judged by their production of IFNg
unstimulated T cell lines was as follows: WT, 77±341 cpm; TKO,(Figure 3).
80±195 cpm. The range of responses at maximal stimulation was
as follows: WT, 6,232±21,580 cpm; TKO, 15,547±59,593 cpm.
Analysis of the Preimmune T Cell Repertoire
Eight preferred CDR3 features have been identified
in PCC 81-104/I-Ek±responsive Va111Vb31 T cells directly analyzed from lymph node CD41 Va111Vb31 T
cells. A comparison of some key TCR features of CD41(McHeyzer-Williams et al., 1999). One of these, the pres-
ence of a glutamic acid at position 93 of Va11 at the Va111Vb31 T cells from unimmunized wild-type cells
and TKO mice is shown in Figure 6B. The use of theseV-J border (Va93E), precedes exposure to PCC and is
found in the majority of preimmune Va111Vb31 T cells, features in activated CD41 T cells from PCC-immunized
mice (MEM) is shown for comparison. While in wild-typeindicating that these cells are positively selected in H-2k
animals. A direct comparison of resting CD41 cells from preimmune cells the predominant Va used is Va11.1
(78%), the same Va used in the large majority of PCC-unprimed wild-type and TKO mice revealed that in the
latter there was a modest (25%) but reproducible de- responsive T cells, half of the Va111Vb31 T cells from
TKO mice used Va11.2. Furthermore, whereas Va93Ecrease in the relative fraction of cells bearing Va11Vb3
among the CD41 population (wild type: 0.61% 6 0.04%, is present in 55% of preimmune and 82% of antigen-
exposed wild-type Va11.11Vb31 T cells, it was foundn 5 4; TKO: 0.46% 6 0.1%, n 5 3; p 5 0.006) (Figure
6A). To determine if alterations in thymocyte selection in only 23% of preimmune TKO Va11.11Vb31 T cells.
Another feature characteristic of the PCC 81-104 im-could be detected at the molecular level in the preim-
mune repertoire of TKO mice, CDR3 sequences were mune response is a serine at position 95 of Va11.1
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Figure 6. Molecular Analysis of the Preimmune Va111Vb31 TCR Repertoire
(A) Resting Va11Vb3-expressing TH cells from B10.BR (WT) and B10.BR.TKO (TKO) mice were isolated as PIneg, (CD8, B220, CD11b)neg,
intermediate for forward and obtuse scatter, positive for both Va11 and Vb3, and low for CD44 and high for CD62L (naive T cells). The percent
noted above the small insert box in the middle panel indicates the percent of Va111Vb31 cells in the CD41 population (gated in the first
panel). One representative experiment is shown (WT, n 5 4; TKO, n 5 3) as 5% probability contours with outliers.
(B±D) Shown are summaries of TCR repertoire analysis. Individual resting Va11Vb3-expressing TH cells as described in (A) from either B10.BR
and B10.BR.TKO mice were directly sorted into cDNA reaction mix and processed for DNA sequencing.
(B) Summary of TCRa chain CDR3 analysis. Sequence from 40 TCRa chains from WT and 31 TCRa chains from TKO mice are compared to
51 TCRa chains sequenced from CD41 cells high for CD44 and low for CD62L isolated from B10.BR mice 2±4 days after two immunizations
with PCC protein in Ribi adjuvant (MEM), as described (McHeyzer-Williams et al., 1999). The percent of cells using either Va11.1 or Va11.2 V
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(Va95S). As with 93E, the frequency of this residue in manipulation of endogenous glucocorticoid levels in or-
gan culture had a profound effect on thymocyte survivalpreimmune TKO mice was much less than in preimmune
wild-type mice (7% versus 23%). Taking into account that was abTCR- and ligand-dependent.
Insights into how glucocorticoids might function inthe 55% decrease in the fraction of CD41 cells that are
Va11.11Vb31, in unimmunized TKO mice the frequency thymocyte selection have come from recent studies on
the effects of manipulating endogenous glucocorticoidof Va11.11Vb31 T cells bearing Va93E or Va95S is de-
creased z4- to 5-fold each. Other preimmune TCRa levels on the survival of thymocytes from nontransgenic
MHC-congenic mice (Vacchio et al., 1999). Apoptosisfeatures such as CDR3 length and the use of certain Ja
segments also differ (Figure 6B). In contrast, most of of double-positive thymocytes caused by inhibition of
corticosterone biosynthesis was positively correlatedthe preferred features of the TCRb chain are very similar
between naive wild-type and TKO T cells (Figure 6C). with the number of MHC-encoded molecules expressed,
and in the absence of any available classical MHC geneThe exception to this is Jb use. Jb1.1 and Jb2.3, which
are rarely seen in Va111Vb31 TCRs from preimmune products (a situation in which all thymocyte death is
by ªneglectº), metyrapone actually enhanced thymocytePCC 81-104 immunized mice, are expressed in over
40% of preimmune Va111Vb31 CD41 T cells from TKO viability. Furthermore, inhibition of endogenous gluco-
corticoid production caused the upregulation of activa-mice (Figure 6D). These analyses directly demonstrate
that the TCR composition of the pool from which PCC tion markers such as CD5, an effect that was dependent
upon expression of abTCRs and MHC-encoded mole-81-104±specific T cells is drawn is substantially altered
in TKO animals. cules. Glucocorticoids generally exert their effects on
cellular processes by regulating gene transcription, ei-
ther directly or indirectly via interactions with other mol-Discussion
ecules such as AP-1 and NF-kB (reviewed in Ashwell et
al., 2000). It is by virtue of their inhibitory effects on theAlthough it is generally accepted that whether a thymo-
cyte is to live or die is coupled to the avidity with which transcription of molecules involved in inflammation and
the peripheral immune response that glucocorticoidsits TCR recognizes self-antigen/MHC, the underlying
biological and/or molecular mechanisms are not under- are immunosuppressive. The finding that decreasing
corticosterone production in the thymus resulted in in-stood. The finding that exposure of T cell hybridomas
to glucocorticoids and activating stimuli, either of which creased evidence of TCR- and MHC-dependent activa-
tion and apoptosis led to the proposal that glucocorti-causes apoptosis, results in cell survival (mutual antago-
nism) prompted us to propose that the balance of these coids regulate thymocyte development by blunting the
biological consequences of TCR-mediated activationtwo signaling pathways might regulate thymocyte se-
lection (Zacharchuk et al., 1990, 1991). In this model, signals. In this case, decreasing glucocorticoid activity
enhances the effects of TCR signaling, shifting the selec-glucocorticoids would set the TCR avidity window for
thymocyte selection by preventing TCR-mediated acti- tion windows toward lower TCR avidities for self-anti-
gen/MHC. Thymocytes bearing TCRs that normallyvation-induced thymocyte apoptosis. A key prediction
is that a decrease in glucocorticoid levels or glucocorti- cause positive selection will now undergo negative se-
lection, and some thymocytes with TCRs of insufficientcoid responsiveness should result in the deletion of thy-
mocytes that would otherwise undergo positive selec- avidity for self-antigen/MHC to rescue them from the
default death pathway will now be positively selected.tion. In fact, considerable evidence has accumulated to
suggest that this is the case. A critical initial finding was If glucocorticoids really antagonize TCR-mediated
signaling in the thymus, the postselection peripheral Tthat steroids are produced by thymic epithelial cells
(Vacchio et al., 1994). The biological relevance of thy- cell antigen-specific repertoire should reflect this recep-
tor cross-talk. GR antisense transgenic mice make itmus-derived glucocorticoids has been supported by fe-
tal thymic organ culture studies in which endogenous possible to test this. Because they are driven by the lck
proximal promoter, antisense transcripts are expressedcorticosterone production was prevented by metyra-
pone, a selective inhibitor of the enzyme P450c11 and in thymocytes but not peripheral T cells, and as a conse-
quence, thymocytes but not T cells are hyporesponsivethus of corticosterone/cortisol biosynthesis. In support
of the mutual antagonism model, inhibition of glucocorti- to glucocorticoids (King et al., 1995; Tolosa et al., 1998).
We have previously introduced this transgene into auto-coid production induced apoptosis of double-positive
thymocytes from female H-2b mice expressing a trans- immune-prone MRL-lpr/lpr mice, and animals homozy-
gous for the transgene were found to have substantiallygenic abTCR that normally leads to positive selection in
this haplotype (Vacchio and Ashwell, 1997). Importantly, reduced autoimmune disease and accumulation of
CD42CD82 T cells (Tolosa et al., 1998). It is noteworthymetyrapone had no effect on otherwise identical thymo-
cytes of the H-2d (nonselecting) haplotype. Therefore, that the expression of certain TCR Vbs that are positively
region gene segments, Va11.1-expressing cells with glutamic acid (E) at TCRa position 93, serine (S) at TCRa position 95, CDR3 length of 8
amino acids and Ja 16, 22, 34, or 17 usage are shown.
(C) Summary of TCRb chain CDR3 analysis. Sequences from 48 TCRb chain from WT and 36 TCRb chain from TKO mice are compared to
42 TCRb chain sequences from CD44hiCD62Llo T cells isolated from B10.BR mice 2±4 days after secondary immunization with PCC protein
in Ribi adjuvant (MEM) (McHeyzer-Williams et al., 1999). The percent of cells with asparagine (N) at TCRb position 100, alanine (A) or glycine
(G) at TCRb position 102, CDR3 length of 9 amino acids, and Jb 1.2, 2.5, 1.1, or 2.3 usage are shown.
(D) Distribution of Jbs used is represented as the percent of Va111Vb31 cells expressing a particular Jb gene segment in WT (upper panel)
compared to TKO mice (lower panel).
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selected in H-2k mice and are therefore overrepresented analysis of the preimmune CD41 Va111Vb31 T cell rep-
ertoire. The frequency of Va111Vb31 CD41 T cells waswas reduced toward the levels found in nonselecting
haplotypes. However, it was not possible to examine the decreased z25% in TKO mice, and of these the repre-
sentation of Va11.1, preferred in the PCC response, wasantigen-specific repertoire directly in this spontaneous
autoimmune model. decreased by z40%, so that there was a .50% de-
crease in the relative representation of Va11.11Vb31In the present study, the immune repertoire of TKO
mice was directly probed by analyzing the T cell re- among CD41 T cells. Furthermore, the prevalence of
preexisting CDR3 features that are preferentially utilizedsponse to a defined antigen. In H-2k mice, the majority
of PCC 81-104±specific T cell clones express TCRs with in the PCC 81-104 response was substantially reduced,
especially with regard to Va11 attributes such as Va93E,the Va11 and Vb3 variable regions and have restricted
heterogeneity in the third hypervariable region (CDR3) Va95S, a CDR3 length of 8 amino acids, and the use of
particular Ja gene segments. Thus, the TKO animals(Fink et al., 1986; Winoto et al., 1986; Matis et al., 1987;
Jorgensen et al., 1992; Davis et al., 1995; McHeyzer- are nonresponsive because the T cells that normally
respond to PCC 81-104 are greatly diminished in num-Williams et al., 1999). It is noteworthy that although
Va111Vb31 T cells were much more highly represented ber, leaving a ªholeº in the antigen-specific T cell reper-
toire. In contrast to PCC 81-104, the quantitative re-in the B10.BR primary response than would be expected
based upon their frequency prior to immunization, they sponse to PPD (this study) and alloantigen (Tolosa et
al., 1998) was indistinguishable between TKO and wild-were clearly a minority population even 7 days after
immunization, comprising about 8% of the IFNg-produc- type animals. Changing the anti-self/MHC avidity win-
dow of positive selection would be expected to alter theing CD41 cells. Yet, in agreement with the literature,
Va111Vb31 TCRs were expressed by the large majority repertoire of TCRs that can respond to these antigens as
well, but not in a predictable manner. That is, TCRs onof the cells in PCC 81-104±specific T cell lines. To our
knowledge, these data provide the first direct estimate positively selected thymocytes in TKO mice that nor-
mally have inadequate avidity for self-antigen to be se-of the fraction of CD41 PCC-responsive cells that are
Va111Vb31 in the primary immune response. There is a lected may have lower or indeed even higher avidity
for a given foreign antigen. Although the primary TCRprevious report in which the number of CD41 T cells
with an activated phenotype after immunization of sequences of the responding cells may be different,
for complex antigens with many epitopes, the immuneB10.BR mice with PCC was enumerated, which should
provide an indirect measure of TCR use in the primary response would be preserved. Together, these results
demonstrate that glucocorticoids affect the composi-response (McHeyzer-Williams et al., 1996). Six days after
immunization, there was an increase of 9.25 3 105 tion of the antigen-specific repertoire and that manipula-
tion of glucocorticoid responsiveness can convert a ªre-CD44hiCD41 T cells. Of these, 3.5 3 104 (4%) were
Va111Vb31. Since z30% of the activated CD41 T cell sponderº animal into a ªnonresponder.º The question
of whether increased responsiveness to glucocorticoidsincrease was in response to the adjuvant, to which there
is no anticipated bias toward Va111Vb31 T cells, it can would result in the reciprocal situation, the positive se-
lection of thymocytes that would ordinarily undergo neg-be estimated that z6% of the CD41 T cells activated
by PCC expressed a TCR containing Va11 and Vb3. ative selection, is currently under study.
Although these calculations provide only a rough esti-
Experimental Proceduresmate, the result is very similar to our direct determination
of PCC-responsive CD41 T cells and supports the obser-
Micevation that Va111Vb31 T cells do not in fact dominate the
B10.A(4R), B10.A(5R), and the original breeding pairs of B10.BRearly primary immune response to PCC 81-104. There is, mice were obtained from the Jackson Laboratory. B10.BR.TKO mice
however, clearly a selection advantage for Va111Vb31 were generated by backcrossing the original TKO mice that express
T cells, and they become the dominant clones upon a transgenic antisense GR 39 UT under the control of the proximal
lck promoter (King et al., 1995) onto the C57BL/6 background forrepeated antigen stimulation. A similar selection for par-
eight generations and then crossing these animals with B10.BRticular features that characterize the CDR3 region of the
mice to generate mice homozygous for the GR antisense transgenePCC-responsive Va111Vb31 T cell population has been
and H-2k (B10.BR.TKO). The antisense transgene was detected bynoted during the course of primary and secondary im- fluorescence in situ hybridization of peripheral blood cells as de-
mune responses to PCC 81-104 (McHeyzer-Williams scribed (Tolosa et al., 1998).
and Davis, 1995). The simplest explanation of these re-
sults is that Va111Vb31 T cells outgrow others because Cells and Antibodies
P13.9 are fibroblasts stably transfected with cDNA constructs en-of a higher avidity for PCC 81-104/I-Ek. It should be
coding I-Ek and B7 and were used to present the antigen PCCpossible to test this possibility by correlating the TCR
81-104 (Ding et al., 1993). Anti-CD3 (clone 145-2C11, fluoresceinprimary structure with avidity, as measured with PCC/
isothiocyanate [FITC] labeled), anti-TCR Va11 (RR8-1, phycoerythrin
I-Ek tetramers (Crawford et al., 1998). [PE] or biotin labeled), anti-TCR Vb3 (KJ25, biotin, or PE labeled),
Although B10.BR.TKO animals responded normally to anti-TCRb (H57-597, FITC labeled), anti-CD45R/B220 (RA3-6B2, PE
labeled), anti-IFNg (XMG1.2, FITC labeled), anti-IL-4 (BVD4-1D11, PEthe complex antigen PPD, the proliferative response to
labeled), and anti-CD8 (53-6.7) were purchased from PharMingen.PCC 81-104 was almost nonexistent. Precursor analysis
Supernatant from 2.4G2 cells was used as the source of this ratand evaluation of PCC 81-104±specific T cell lines indi-
anti-mouse Fc receptor antibody (Unkeless, 1979).
cated that this ªnonresponderº status was due to a
sharp decrease in antigen-responsive precursors and Antigens and Immunization
most likely a lower avidity of the remaining responsive Pigeon cytochrome c COOH-terminal fragment 81-104 (PCC 81-
104) was purchased from Macromolecular Resources. Mice at 10±20T cells for PCC 81-104/I-Ek. This was supported by an
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weeks of age were immunized in the base of the tail and the hind washed twice in FACS buffer 1 and then fixed in 4% paraformalde-
hyde at room temperature. After 20 min, the cells were washed twicefootpads with a total of 8 nmol of peptide emulsified 1:1 in CFA
(Sigma). Purified protein derivative (PPD) was purchased from in FACS buffer 2 (FACS buffer 1 plus 0.1% saponin) and stained
with anti-cytokine monoclonal antibodies in FACS buffer 2 at roomParke-Davis.
temperature for 30 min. After washing twice more with FACS buffer
2, the cells were resuspended in FACS buffer 1 and analyzed withT Cell Lines
a FACSCalibur (Becton Dickinson). The frequency of respondingLymph node cells from two B10.BR and two B10.BR.TKO mice were
cell subsets was determined by comparing Va and Vb expressionremoved 8±12 days after antigen priming to establish T cell lines.
on antigen-responsive (IFNg1) and -unresponsive CD41 cells.Lymph node cells/well (2.5 3 106) were placed in 24-well flat-bottom
dishes with 5 3 106 irradiated (30 Gy) B10.BR spleen cells in a total
Single-Cell Repertoire Analysisvolume of 1 ml of RPMI 1640 (Biofluids) supplemented with 10%
Single-cell repertoire analysis was performed as describedheat-inactivated fetal calf serum, 100 mg/ml gentamicin, 100 U/ml
(McHeyzer-Williams et al., 1999). Briefly, single cells were sortedpenicillin, 4 mM glutamine, and 50 mM 2-mercaptoethanol (complete
using the automatic cell dispensing unit (ACDU) attached to themedium). PCC 81-104 was added at a final concentration of 5 mM.
FACStar Plus (Becton Dickinson) and CloneCyt software (BectonCell lines were expanded by antigen stimulation (5 mM PCC 81-
Dickinson). Each cell was sorted into a well of a low profile 72-104 plus 5 3 106 irradiated B10.BR splenocytes) every 8±12 days
well microtiter tray (Robbins Scientific) containing 5 ml of oligo d(T)followed 48 hr later by the addition of 20 U of recombinant human
primed cDNA reaction mix. Two microliters of cDNA from single-IL-2 (Hoffman-La Roche).
cell cDNA reactions was used for two separate 25 ml amplification
reactions, one for TCR Va11 and one for TCR Vb3, using primersT Cell Proliferation Assay
specific for the V regions and the constant regions of each chain.The assay was carried out in 96-well flat-bottom microtiter plates.
For the first rounds of PCR (PCR-a), each reaction set began atT cells from draining lymph nodes of primed mice were enriched
958C for 5 min, followed by 40 cycles of 958C for 15 s, 508C for 45by removing B cells with goat anti-mouse immunoglobulin G (IgG)±
s, and 728C for 90 s and ended at 728C for 5 min. One microliter of thecoupled magnetic beads (PerSeptive Systems). The cells purified
first round of PCR product was used for further 25 ml amplificationby this method were 90%±95% positive for TCRb chain. For T cell
reactions for each chain of the TCR, using primers nested mediallylines, 104 T cells or, for lymph node cells, 105 T cells were incubated
to the primers used in PCR-a. Each reaction set began at 958C forwith 5 3 105 irradiated (30 Gy) B10.BR spleen cells and the indicated
5 min, followed by 35 cycles of 958C for 15 s, 558C for 45 s, andconcentrations of antigen in a total volume of 200 ml of complete
728C for 90 s and ended with 728C for 5 min. At least two negativemedium. After 48 hr (T cell lines) or 96 hr (lymph node cells), the
cDNA samples were processed per ten single-cell samples. Thewells were pulsed with 1 mCi [3H]thymidine, and 18 hr later the
negatives were interspersed with positives to control for contamina-wells were harvested and the incorporation of radioactivity was
tion during sample preparation. The PCR product was separateddetermined by liquid scintillation counting.
from the primers using a CL-6B Sepharose (Pharmacia) column.
Samples were separated on a 6.5% acrylamide gel after ethanolFlow Cytometry
precipitation of sequencing reaction products, run on an ABI 373For analysis of T cells purified from draining lymph nodes of immu-
sequencing system, and processed using ABI Prism sequence 2.1.2nized animals or T cell lines, 0.5±1 3 106 viable cells per tube were
for collection and analysis (Perkin Elmer). The frequency for ob-washed in staining buffer (PBS with 5% bovine serum albumin and
taining a sequencable PCR product from single cells varied between0.1% NaN3) and pelleted. To block nonspecific binding, the cells TCRa (WT, 31%; TKO, 20%; n 5 160) and TCRb (WT, 67%; TKO,were resuspended in 10 ml of a rat monoclonal antibody specific
68%; n 5 160) (primarily due to lower abundance of TCRa mRNAfor mouse Fc receptor (2.4G2). After a 10 min incubation, 10 ml of
per cell).monoclonal antibody at the appropriate dilution in FACS buffer was
added and further incubated for another 30 min at 48C. The cells
Acknowledgmentsstained with biotin-labeled antibody were developed with cychrome-
conjugated avidin. Finally, the cells were resuspended in stain-
We are grateful to Eva Tolosa and Melanie Vacchio for helpful sug-ing buffer and analyzed with a FACScan (Becton Dickinson). For
gestions and advice.five-color flow cytometry, analysis of inguinal and periaortic lymph
nodes from unimmunized mice was performed as previously de-
Received September 13, 1999; revised January 10, 2000.scribed (McHeyzer-Williams et al., 1999). Briefly, cells were stained
with Cy5PE-6B2 (anti-B220) (PharMingen), Cy5PE-53-6.7 (anti-CD8)
References(PharMingen), Cy5PE-M1/70.15 (anti-CD11b) (Caltag Laboratories),
FITC-RR8.1 (anti-Va11) (PharMingen), APC-KJ25 (anti-Vb3), PE-
Ashwell, J.D., Lu, F., and Vacchio, M.S. (2000). Glucocorticoids inMel14 (anti-CD62L) (PharMingen), and Texas red (TR)-IM7 (anti-
T cell development and function. Annu. Rev. Immunol., in press.CD44). In some experiments, PE-H129.19 (anti-CD4) (PharMingen),
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Cy5PE-CT-CD4 (anti-CD4) (Caltag Laboratories) were used. After (1998). Detection of antigen-specific T cells with multivalent soluble
staining for 45 min on ice, cells were washed twice with PBS plus class II MHC covalent peptide complexes. Immunity 8, 675±682.
5% fetal calf serum and resuspended in PBS with 5% fetal calf Davis, M.M., McHeyzer-Williams, M., and Chien, Y.H. (1995). T-cell
serum and 2 mg/ml propidium iodide (PI) to exclude dead cells. receptor V-region usage and antigen specificity. The cytochrome c
Samples were analyzed using a dual laser modified FACStar Plus model system. Ann. NY Acad. Sci. 756, 1±11.
(Becton Dickinson Immunocytometry Systems). Files were acquired
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using CellQuest software (Becton Dickinson) and analyzed using
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